LIPO (Lipella Pharmaceuticals) Insider Ownership: 38.45 % (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lipella Pharmaceuticals Insider Ownership?

Lipella Pharmaceuticals LIPO Insider Ownership is 38.45 % as of Aug. 08, 2026. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lipella Pharmaceuticals's insider ownership is 38.45%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lipella Pharmaceuticals's Institutional Ownership is 0.06%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lipella Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 95.69%.

Lipella Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Lipella Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Insider Ownership Chart

Lipella Pharmaceuticals Historical Data

The historical data trend for Lipella Pharmaceuticals can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 39.77 38.45 38.45 38.45 38.45 38.45 38.45 38.45 38.45 38.45

Lipella Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 38.45 % mean?
Lipella Pharmaceuticals (LIPO) has a Insider Ownership of 38.45 % as of Aug. 08, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Lipella Pharmaceuticals and its competitors.
Is Lipella Pharmaceuticals' Insider Ownership too high?
Lipella Pharmaceuticals' current Insider Ownership is 38.45 %.
How does Lipella Pharmaceuticals' Insider Ownership compare to SIGY and CNBX?
Lipella Pharmaceuticals' Insider Ownership of 38.45 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Lipella Pharmaceuticals and its competitors. Lipella Pharmaceuticals's current Insider Ownership is 38.45 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipella Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lipella Pharmaceuticals (LIPO) is currently considered Possible Value Trap. The stock's GF Value™ is $8.79, compared to a current price of $0.00 — trading 100% below its estimated fair value. The current Insider Ownership is 38.45 %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Lipella Pharmaceuticals (LIPO), the current Insider Ownership is 38.45 % as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.